Literature DB >> 2418453

Effects of ECT on sleep and CSF biogenic amines in affective illness.

G Hoffmann, P Linkowski, M Kerkhofs, D Desmedt, J Mendlewicz.   

Abstract

The effects of electroconvulsive therapy (ECT) on sleep and cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) were studied in 11 male patients suffering from major depressive disorders severe enough to require ECT. Total sleep time and sleep efficiency index increased significantly after ECT, while the number of awakenings, the ratio wake/total sleep time, and the time of intermittent awake decreased, indicating that sleep continuity improved after treatment. Sleep architecture was also favorably influenced by ECT as shown by a significant increase in time of stage 2 and rapid eye movement (REM) sleep. REM latency and REM density also normalized after ECT. CSF 5HIAA increased significantly after ECT, but this was not the case for CSF HVA. These results demonstrate a positive effect of ECT on sleep EEG and CSF neurochemical markers for depressive illness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418453     DOI: 10.1016/0165-1781(85)90107-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Platelet serotonin transport after a single ECT.

Authors:  J L Rausch; C L Rich; S C Risch
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Non-Invasive Brain Stimulation Effects on Biomarkers of Tryptophan Metabolism: A Scoping Review and Meta-Analysis.

Authors:  Cristian G Giron; Tim T Z Lin; Rebecca L D Kan; Bella B B Zhang; Suk Yu Yau; Georg S Kranz
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

3.  Local and Transient Changes of Sleep Spindle Density During Series of Prefrontal Repetitive Transcranial Magnetic Stimulation in Patients With a Major Depressive Episode.

Authors:  Takuji Izuno; Takashi Saeki; Nobuhide Hirai; Takuya Yoshiike; Masataka Sunagawa; Motoaki Nakamura
Journal:  Front Hum Neurosci       Date:  2022-01-06       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.